Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAK-701 |
Trade Name | |
Synonyms | HuL2G7 |
Drug Descriptions |
TAK-701 is a monoclonal antibody that targets HGF and prevents its binding to MET, resulting in decreased activation of HGF/MET signaling and potentially resulting in increased tumor cell death (PMID: 24019233). |
DrugClasses | HGF Antibody 4 |
CAS Registry Number | NA |
NCIT ID | C81939 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gefitinib + TAK-701 | Gefitinib TAK-701 | 0 | 0 |
TAK-701 | TAK-701 | 0 | 0 |